Michael Chang is a Managing Partner at Vivo Capital, a healthcare-focused venture capital firm. See sector focus and contact routes.
Michael Chang is a Managing Partner at Vivo Capital, a healthcare-focused venture capital firm, where he joined in 2012 with prior experience in healthcare strategy and operations at Johnson & Johnson and as a consultant at Booz & Company and Fletcher Spaght. His investment thesis centers on supporting global life sciences startups at early stages, specifically pre-seed and seed, with enterprise-scale innovations in healthcare. Vivo Capital typically writes checks ranging from $1.0 million to $10.0 million, though the firm’s specific lead or follow behavior for Chang is not publicly detailed. Notable portfolio companies of Vivo Capital include Amgen, Illumina, and Medtronic, reflecting its focus on established and emerging healthcare leaders, though Chang’s direct personal portfolio is not explicitly listed in available sources. Vivo Capital specializes in healthcare and life sciences, operating primarily in the United States with a global outlook, but Chang’s specific geographic preferences beyond this are not confirmed. There is no publicly available distinctive point of view, public writing, or commentary attributed specifically to Michael Chang in the searc
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in San Francisco when building a target list.
Investors like Michael Chang · Full investor directory · Investor access · Company funding database